Related Experiment Video
Updated: Mar 31, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
[HISTOLOGICAL ANALYSIS OF BONE DESTRUCTION IN SPINAL TUBERCULOSIS]
Purpose:
To investigate the mechanism of bone destruction in spinal tuberculosis (TB) by immunohistochemical analysis of the pathway that includes receptor activator of NF-κB (RANK), receptor activator of NF-κB ligand (RANKL), osteoprotegerin (OPG), and osteocalcin (OCN) in affected tissues.
Materials And Methods:
TB bone specimens were obtained from 30 surgically treated spinal TB patients (13 males and 17 females; average age, 67 years). Normal bone specimens were also obtained from 30 osteoarthritis patients (12 males and 18 females; average age, 70 years) who had undergone knee arthroplasty, wherein a piece of the non-weight-bearing part of the femur was obtained as a part of the resected bone for surgery. The two groups of specimens were examined for the expression of RANK, RANKL, OPG, and OCN by immunohistochemistry.
Results:
Spinal TB specimens were significantly infiltrated by inflammatory cells, and bone resorption by multinucleated osteoclasts was observed. RANKL was predominantly expressed in lymphocytes and osteoblasts, whereas RANK was expressed in mononucleated osteoclast precursors among the inflammatory cells. In contrast, there was no infiltration of the inflammatory cells, and the expression of RANKL/RANK was poor in the control specimens. OCN, a bone formation marker, was expressed in the osteoblasts and in part of the bone matrix in normal tissues; however, it was poorly expressed in the tissues of the spinal TB patients. OPG, a neutralizer of the RANK-RANKL pathway, was expressed in the osteoblasts and stromal cells, and there was no significant difference in the expression between the two groups.
Discussion:
In the tissues from spinal TB patients, the RANK-RANKL pathway was strongly activated, whereas the expression of its neutralizer OPG was not sufficiently induced. In addition, the bone formation marker OCN was poorly expressed, indicating a paucity of reactive bone formation. These findings are consistent with bone-resorption-predominant destruction, which is commonly observed in osteoarticular TB. Activation of the RANK-RANKL pathway has been considered to be caused by cytokines such as tumor necrosis factor-α and interleukin-6, which also play important roles in the immune response against TB. In severe pulmonary TB, an intense and prolonged immune reaction sometimes leads to tissue destruction and the formation of cavity lesions. Therefore, such an immune reaction against spinal TB may also cause activation of the RANK-RANKL pathway, thereby leading to bone destruction.
Insights
Spinal tuberculosis (TB) activates the receptor activator of NF-κB (RANK) and RANK ligand (RANKL) pathway, leading to bone destruction. This pathway
Area of Science:
- Immunohistochemistry
- Molecular biology
- Orthopedic pathology
Context:
- Spinal tuberculosis (TB) is a destructive bone disease.
- Understanding the molecular mechanisms of bone destruction in spinal TB is crucial for developing targeted therapies.
- The receptor activator of NF-κB (RANK) signaling pathway plays a key role in bone remodeling.
Purpose:
- To investigate the role of the RANK, RANKL, osteoprotegerin (OPG), and osteocalcin (OCN) pathway in spinal TB bone destruction.
- To compare the expression of these markers in spinal TB tissues versus normal bone tissues.
Summary:
- Spinal TB tissues showed significant inflammatory cell infiltration and osteoclast-mediated bone resorption.
- The RANK-RANKL pathway was highly activated in spinal TB, with RANKL expressed in inflammatory cells and osteoblasts, and RANK in osteoclast precursors.
- Bone formation markers (OCN) were reduced, and OPG, a RANKL inhibitor, was not sufficiently upregulated, indicating a net bone-resorptive state.
Impact:
- Findings suggest that the activated RANK-RANKL pathway, potentially driven by TB-related cytokines, is a primary driver of bone destruction in spinal TB.
- This study highlights the imbalance between bone resorption and formation in spinal TB.
- Provides a molecular basis for understanding osteoarticular TB pathogenesis and suggests potential therapeutic targets.
More Related Videos
10:39Longitudinal Evaluation of Mouse Hind Limb Bone Loss After Spinal Cord Injury using Novel, in vivo, Methodology
Published on: December 7, 2011
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...